Compare RZLT & ASTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RZLT | ASTE |
|---|---|---|
| Founded | 2010 | 1972 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Construction/Ag Equipment/Trucks |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 326.4M | 1.3B |
| IPO Year | 2011 | 2002 |
| Metric | RZLT | ASTE |
|---|---|---|
| Price | $3.05 | $61.70 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $9.17 | N/A |
| AVG Volume (30 Days) | ★ 2.4M | 197.9K |
| Earning Date | 05-27-2026 | 05-27-2026 |
| Dividend Yield | N/A | ★ 0.81% |
| EPS Growth | 26.32 | ★ 784.21 |
| EPS | N/A | ★ 1.68 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $6.35 |
| Revenue Next Year | N/A | $2.27 |
| P/E Ratio | ★ N/A | $38.11 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.07 | $29.65 |
| 52 Week High | $11.46 | $64.37 |
| Indicator | RZLT | ASTE |
|---|---|---|
| Relative Strength Index (RSI) | 43.63 | 66.69 |
| Support Level | $2.80 | $44.05 |
| Resistance Level | $4.21 | N/A |
| Average True Range (ATR) | 0.34 | 2.84 |
| MACD | -0.02 | 0.20 |
| Stochastic Oscillator | 10.78 | 74.48 |
Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causing excessive insulin production and resulting hypoglycemia. Rezolute's pipeline includes drug candidates designed to improve patient outcomes while reducing treatment burdens. The company engages in research, development, and clinical trials to advance its therapies and collaborates with medical communities and patient groups to support its objectives. Revenue and value creation depend largely on successful product development and regulatory approvals.
Astec Industries Inc designs and manufactures equipment and components used in road construction and other development activities. Its products are used through the entire process of building roads, from mining and crushing materials to creating the road surface. The company manufactures a line of plants, pavers, vehicles, and machines to mix and transform materials into construction components. It has two operating segments: infrastructure solutions generating maximum revenue and materials solutions. The majority of sales are derived from the United States. Its customers are asphalt producers, highway and heavy equipment contractors, ready mix concrete producers, demolition recycling markets, sand and gravel producers, open mine operators, quarry operators, and others.